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Adult peripheral neurons, in contrast to adult central neurons, are capable of regeneration
after axonal damage. Much attention has focused on the changes that accompany this
regeneration in two places, the distal nerve segment (where phagocytosis of axonal
debris, changes in the surface properties of Schwann cells, and induction of growth
factors and cytokines occur) and the neuronal cell body (where dramatic changes in
cell morphology and gene expression occur). The changes in the axotomized cell body
are often referred to as the “cell body response.” The focus of the current review is a
family of cytokines, the glycoprotein 130 (gp130) cytokines, which produce their actions
through a common gp130 signaling receptor and which function as injury signals for
axotomized peripheral neurons, triggering changes in gene expression and in neurite
outgrowth. These cytokines play important roles in the responses of sympathetic,
sensory, and motor neurons to injury. The best studied of these cytokines in this
context are leukemia inhibitory factor (LIF) and interleukin (IL)-6, but experiments with
conditional gp130 knockout animals suggest that other members of this family, not yet
determined, are also involved. The primary gp130 signaling pathway shown to be involved
is the activation of Janus kinase (JAK) and the transcription factors Signal Transducers
and Activators of Transcription (STAT), though other downstream pathways such as
mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) may
also play a role. gp130 signaling may involve paracrine, retrograde, and autocrine actions
of these cytokines. Recent studies suggest that manipulation of this cytokine system can
also stimulate regeneration by injured central neurons.
Keywords: axotomy, conditioning lesion, galanin, gp130 cytokine, neuropeptide, regeneration associated genes,
sympathetic ganglion, vasoactive intestinal peptide
RESPONSES OF THE DISTAL NERVE AND THE AXOTOMIZED
CELL BODY AFTER PERIPHERAL NERVE TRANSECTION
Following injury to an adult peripheral nerve trunk resulting from
transection, crushing, or freezing, the axonal segments distal to
the site of injury degenerate. This process occurs over a period
of a few days, involves axonal degeneration and phagocytosis
by infiltrating macrophages and Schwann cells, and is referred
to as Wallerian degeneration (Vargas and Barres, 2007; Gaudet
et al., 2011). While this was previously thought to be a totally
passive process as a consequence of the severed axons being
cut off from the vast array of proteins normally supplied from
their cell bodies via axonal transport, studies over the last 25
years have shown that not to be the case. In the slow Wallerian
degeneration mouse (Wlds), axonal degeneration after a lesion
can take several weeks (Deckwerth and Johnson, 1994; Coleman
and Freeman, 2010).
At the same time that clearance of axonal debris occurs in
the distal nerve stump, a suitable pathway is created through
which regenerating axons eventually reach appropriate targets
(Fu and Gordon, 1997; Barrette et al., 2010). In addition, the
non-neuronal cells that make up this structure, particularly the
Schwann cells and macrophages, begin to synthesize a variety
of trophic factors and cytokines (Gordon, 2009; Barrette et al.,
2010). These molecules are clearly neuroactive and many pro-
mote neurite outgrowth when given exogenously, and, therefore,
it is often assumed that they promote regeneration in vivo, though
there has been little direct evidence for this hypothesis. For exam-
ple, following transection of the sciatic nerve it has been shown
that the neurotrophin receptor p75 and the neurotrophin nerve
growth factor (NGF) are up-regulated by non-neuronal cells, and
it was originally proposed that NGF binding to these receptors
played an important role in sensory and sympathetic nerve regen-
eration (Taniuchi et al., 1986; Heumann et al., 1987; Taniuchi
et al., 1988). However, evidence from Diamond and colleagues
and others demonstrated that sensory and sympathetic regener-
ation is not affected by blockade of endogenous NGF, although
under the same conditions collateral sprouting is blocked (Rich
et al., 1984; Diamond et al., 1987, 1992; Gloster and Diamond,
1992, 1995; Doubleday and Robinson, 1995).
Nevertheless, Wallerian degeneration is important for regen-
eration to occur, as slow degeneration has been shown to
retard peripheral nerve regeneration in sensory and motor axons
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(Bisby and Chen, 1990; Brown et al., 1992; Chen and Bisby,
1993a,b). This effect could be the result of a physical barrier
presented by the distal axons, the slow removal of inhibitory
molecules released as a result of the injury, or the delay in secre-
tion of a variety of factors from denervated Schwann cells, and it
is likely to result from all three (Brown et al., 1991, 1992; Perry
and Brown, 1992).
A great deal is known about the cell biology and biochem-
istry of Wallerian degeneration; however, little is known about
the signaling molecules that trigger this process. Recent stud-
ies indicate a role for damage-associated molecular patterns
(DAMPs), which stimulate Toll-like receptors and initiate the
release of subsequent signaling molecules like monocyte chemo-
attractant peptide-1, which plays an important role in triggering
the influx of macrophages (Karanth et al., 2006; Lee et al., 2006;
Boivin et al., 2007).
In contrast to these axonal changes that occur distal to the
site of nerve injury, minimal changes occur in the injured nerve
proximal to the injury except in the region immediately next
to the site of injury (e.g., Heumann et al., 1987; Curtis et al.,
1994); however, dramatic changes occur in the region of the
axotomized neuronal cell bodies. Early evidence of this came
from histological studies in 1892 by Franz Nissl, who described
within 24 h of a peripheral nerve transection dissolution of “Nissl
bodies” (later identified as rough endoplasmic reticulum) in
neurons in the anterior horn, swelling of the nucleus and cyto-
plasm, and a change in the shape and position of the nucleus
(quoted in Leinfelder, 1938). This phenomenon was termed
chromatolysis. On a biochemical level, the axotomized neuronal
cell bodies increase their overall synthesis of both mRNA and
protein (Watson, 1974). When individual mRNAs and proteins
are examined, not surprisingly, one finds both increases and
decreases. For example, axotomized dorsal root ganglia (DRG),
superior cervical sympathetic ganglia (SCG), and facial motor
neurons have been examined by gene microarray analysis, and
substantial changes in individual mRNAs have been documented
(Costigan et al., 2002; Boeshore et al., 2004; Zujovic et al.,
2005). At the protein level, increases and decreases have also
been documented. For example, in sensory and motor neu-
rons increases in tubulin and decreases in neurofilament levels
have been found (Quesada et al., 1986; Greenberg and Lasek,
1988; Oblinger and Lasek, 1988; Tetzlaff et al., 1988) and sim-
ilar changes have been found in the SCG at the mRNA level
(Boeshore et al., 2004). Together these morphological and bio-
chemical changes have been referred to by various investigators
as the cell body response (Grafstein, 1975; Hendry, 1992), the
cell body reaction (Titmus and Faber, 1990), or the axon reac-
tion (Lieberman, 1971; Hanz and Fainzilber, 2006). The genes
whose expression increases after axotomy are referred to as regen-
eration associated genes (RAGs) (Fernandes et al., 1999). It has
often been pointed out that these histological and molecular
biological changes in the axotomized cell body occur at a time
that the neuron shifts its activity from synaptic transmission to
regeneration, and it is hypothesized that the changes underlie
this functional switch (Matthews and Raisman, 1969; Cheah and
Geffen, 1973; Grafstein, 1975; Grafstein and McQuarrie, 1978;
Hyatt-Sachs et al., 1993).
CHANGES IN NEUROPEPTIDE EXPRESSION IN PERIPHERAL
NEURONS AFTER AXOTOMY IN VIVO AND IN CULTURE
One conspicuous change in the cell bodies of adult peripheral
neurons after axotomy is the expression of certain neuropeptides
not previously expressed by these neurons (at least during adult-
hood) and the decreased expression of other peptides that are
normally present (for reviews see Hokfelt et al., 1994; Zigmond
et al., 1996; Zigmond, 1997). For example, following transec-
tion of the two major postganglionic trunks of the SCG, the
internal and external carotid nerves, ganglionic neurons begin
to express vasoactive intestinal peptide (VIP), galanin, pituitary
adenylate cyclase activating polypeptide (PACAP), substance P,
and cholecystokinin (CCK) and down regulate their expression
of neuropeptide Y (NPY) (Hyatt-Sachs et al., 1993; Rao et al.,
1993b; Klimaschewski et al., 1994; Mohney et al., 1994; Schreiber
et al., 1994; Zhang et al., 1994; Klimaschewski et al., 1996; Sun
and Zigmond, 1996a; Moller et al., 1997a; Habecker et al., 2009).
Interestingly, VIP, galanin, and PACAP are also up-regulated
after axotomy of DRG neurons and motor neurons, and there-
fore, should be considered RAGs (Shehab and Atkinson, 1986;
Hokfelt et al., 1987; Moore, 1989; Saika et al., 1991; Zhang et al.,
1995; Zhou et al., 1999; Zigmond, 2001). In the case of CCK,
increases were also reported in the DRG and facial motor nucleus
(Saika et al., 1991; Verge et al., 1993), although a decrease has
been reported in axotomized lumbar motor neurons (Piehl et al.,
1993).
The functional significance of these increases in peptide
expression has not been determined in every case but consider-
able evidence exists that at least some of these changes facilitate
regeneration. Perhaps the best case is for the increase in galanin in
DRGs. Functional regeneration determined by the toe spreading
index was delayed in galanin –/– mice for three weeks after sciatic
nerve crush (Holmes et al., 2000). A somewhat less striking deficit
in regeneration of facial motor neurons and an exaggerated neu-
roinflammatory response were observed in PACAP –/– mice after
facial nerve crush (Armstrong et al., 2008). Both PACAP and VIP,
though not galanin, have been shown to stimulate neurite out-
growth in PC12 cells (Deutsch et al., 1993; Okumura et al., 1994;
Klimaschewski et al., 1995). PACAP also stimulates neurite out-
growth in embryonic DRG and SCG cultures (Lioudyno et al.,
1998; DiCicco-Bloom et al., 2000). On the other hand, galanin
does stimulate neurite outgrowth in cultured adult DRG neurons
(Mahoney et al., 2003; Suarez et al., 2006). In addition, evidence
exists that VIP in the SCG and galanin in the DRG may pro-
mote neuronal survival after injury (Klimaschewski et al., 1995;
Holmberg et al., 2005).
Changes in neuropeptide expression similar to those seen after
axotomy occur in SCG in explant cultures. The first reported
example of this was an increase in substance P protein (Adler
and Black, 1984). Subsequent studies demonstrated increases in
protein levels for VIP, galanin, and PACAP in such preparations
(Zigmond et al., 1992; Schreiber et al., 1994; Moller et al., 1997b).
The simplest explanation for an increase in a neuropep-
tide level in a neuronal cell body after axotomy (or after being
placed in explant culture) is that it is due to the buildup of
neuropeptide that would normally be transported down the axon,
and, in fact, in early experiments, axonal transport blockers
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such as colchicines were used in immunohistochemical studies
to increase detection of normally expressed neuropeptides with
that reasoning in mind (e.g., Moore, 1989). However, in all the
cases cited above, it has been found that the increases in neu-
ropeptides are accompanied by increases in the respective mRNAs
(for reviews see Hokfelt et al., 1994; Zigmond et al., 1996), sug-
gesting they result from increased gene expression and not just
interference with transport away from the cell body.
In sympathetic neurons and motor neurons, axotomy leads
to “synaptic stripping” of the afferent inputs to the neurons
and decreased synaptic transmission (Brown and Pascoe, 1954;
Blinzinger and Kreutzberg, 1968; Matthews and Nelson, 1975),
and, of course, axotomy of the peripheral axonal branch of a
sensory neuron leads to decreased on-going sensory nerve activ-
ity. In early studies, it was proposed that decreased sympathetic
nerve activity leads to the increased expression of substance P
in cultured SCG (Black et al., 1982); however, this interpreta-
tion of these findings has since been questioned (Sun et al.,
1992). In fact, the finding for a variety of neuropeptides that
increase their expression after axotomy in the SCG (i.e., galanin,
PACAP, substance P, VIP) is that their expression also goes up
after depolarization in culture (Sun et al., 1992; Brandenburg
et al., 1997; Klimaschewski, 1997). Furthermore, the increases
in neuropeptide expression seen after cutting the predominantly
preganglionic cervical sympathetic trunk (CST) (i.e., deafferenta-
tion or decentralization of the ganglion), thus silencing neurons
in the SCG, are small compared to those seen after axotomy
(Kessler and Black, 1982; Hyatt-Sachs et al., 1993; Rao et al.,
1993b; Schreiber et al., 1994; Moller et al., 1997a). The few new
peptidergic neurons seen after surgical deafferentation are likely
to be due to a small population of neurons in the SCG that project
their axons into the CST and are thus axotomized and deaffer-
ented by the surgery (Bowers and Zigmond, 1979; Mohney et al.,
1994; Zigmond and Vaccariello, 2007).
Is the induction of these neuropeptides simply caused by
some non-specific trauma produced by the surgery, which, in the
case of the SCG, occurs quite close to the neuronal cell bodies
(Zigmond, 1997)? The minor effect caused by deafferentation,
also performed close to the ganglion, suggests this is not the case
(Zigmond, 1997). Furthermore, injury to the axons of neurons in
the inferior and middle cervical ganglion made at some distance
from their cell bodies produces similar changes in neuropep-
tide expression (Shadiack et al., 1995). Finally, if sympathetic
nerve terminals are lesioned chemically, again at some distance
from their neuronal cell bodies, by administration of the adrener-
gic neurotoxin 6-hydroxydopamine, changes in galanin and VIP
mRNA occur that are comparable to those seen after close surgi-
cal axotomy (Hyatt-Sachs et al., 1996). Distal chemical axotomy of
sensory neurons with capsaicin (Chung et al., 1990) or resinifer-
atoxin, a potent capsaicin analog, lead to an increase in VIP
and galanin mRNA in DRG neurons (Farkas-Szallasi et al., 1995;
Kashiba et al., 1997).
While sympathetic, sensory, and motor neurons respond sim-
ilarly to axotomy with respect to some neuropeptides (i.e.,
VIP, galanin, and PACAP), they differ in terms of others. For
example, after axotomy, substance P is up-regulated in neurons
in the SCG, as noted above, but it is down-regulated in the DRG
(Nielsch and Keen, 1989; Noguchi et al., 1989; Rao et al., 1993b).
In addition, NPY, which is down-regulated in the SCG, is up-
regulated in the DRG (Wakisaka et al., 1991). These results may
reflect differences in the mixture of injury signals released in
different neuronal systems.
LEUKEMIA INHIBITORY FACTOR (LIF) ACTS AS A POSITIVE
INJURY SIGNAL TRIGGERING CERTAIN OF THE CHANGES
IN AXOTOMIZED NEURONS AFTER PERIPHERAL NERVE
INJURY
The signals that trigger retrograde changes in the cell bodies
after axotomy have long been sought. In 1970, Cragg wrote a
review paper entitled “What is the signal for chromatolysis” in
which he addressed this question. Interestingly, this paper pre-
sented no new data. Rather in it Cragg enumerated 10 possible
signals including changes in neural activity (such as immediate
increases due to the injury itself or subsequent decreases due to
synaptic stripping) and changes in the axonal transport of mate-
rials, either orthogradely or retrogradely. This field lay fallow for a
number of years; however, eventually investigators began thinking
in terms of positive and negative signals (Ambron and Walters,
1996). Positive signals were conceived of as molecules, which were
not present, at least in their active form, in intact neurons but
were produced in response to axotomy and stimulated aspects of
the cell body response. Negative signals were the opposite, that is,
they were present in intact neurons, normally suppressing the cell
body response, but triggering this response when their influence
was removed following axotomy.
Using induction of specific neuropeptides in the SCG after
axotomy, we identified both a positive and a negative signal
(Zigmond, 1997). The negative signal is nerve growth factor,
which is normally taken up by sympathetic and sensory nerve
endings from their peripheral target tissues and retrogradely
transported back to the cell body (Oppenheim, 1996). Blockade
of this on-going signal in unoperated animals with an antiserum
to NGF produces a number of the changes in gene expression
normally seen after axotomy (Zigmond, 1997; Shadiack et al.,
1998, 2001). This system will not be discussed further in this
article except in the case of NGF’s modulation of the effects of
glycoprotein 130 (gp130) cytokines.
Evidence for a positive signal first came from dissociated cell
culture experiments. Following dissociation of neonatal SCG and
plating of both the neurons and non-neuronal cells, VIP-like
immunoreactivity (IR) increases 10–20-fold (Sun et al., 1992,
1994). When the dissociated cells were pre-plated to remove the
non-neuronal cells, the increase in VIP-IRwas greatly diminished.
If, on the other hand, culture medium was preconditioned by
ganglion non-neuronal cells and then placed on neuron-enriched
cultures, it caused a 4-fold induction of peptide levels compared
to cultures treated with control medium (Sun et al., 1994).
In examining the chemical nature of the active component
of the conditioned medium, we were influenced by earlier stud-
ies showing that exogenous application of two cytokines of the
gp130 family, namely leukemia inhibitory factor (LIF) and ciliary
neurotrophic factor (CNTF), which had originally been shown to
trigger a switch in neonatal sympathetic neurons in culture from
an adrenergic to a cholinergic phenotype (Saadat et al., 1989;
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Yamamori et al., 1989), also induced VIP expression (Ernsberger
et al., 1989; Nawa et al., 1991). For this reason, we examined
the effects of immunoprecipitating the non-neuronal cell con-
ditioned medium with antibodies to LIF and CNTF (Sun et al.,
1994). The anti-LIF antiserum completely blocked the stimula-
tory effect of the conditioned medium on VIP expression. On the
other hand, anti-CNTF had no such effect. The anti-LIF neutral-
izing antiserum also reduced the increase in VIP-IR in explanted
adult ganglia compared to the effect of normal serum, and this
effect of the antiserum could be overcome by addition of human
recombinant LIF, which is not recognized by the antiserum (Sun
et al., 1994).
Only a very faint band with the mobility of LIF was found
on gels after PCR of extracts from control ganglia. However, a
strong signal for LIF was seen in extracts of ganglionic non-
neuronal cells cultured for 48 h, in SCG explants after 48 h, and
in extracts of SCG dissected 48 h after axotomy (Sun et al., 1994).
Later studies using real-time PCR established that LIF mRNA was
detectable in the axotomized SCG by 6 h and those levels were
maintained for at least 48 h (Habecker et al., 2009). By in situ
hybridization and Northern blot analysis, it was shown that the
increase in LIF mRNA in vivo, as indicated by our cell culture
experiments, occurs in non-neuronal cells, and it was suggested
that these were satellite/Schwann cells (Banner and Patterson,
1994; Nagamoto-Combs et al., 1999). Studies in a rat Schwann
cell line revealed that LIF mRNA levels were increased follow-
ing treatment of the cells with either phorbol myristate acetate
(PMA), a cAMP analog, or a calcium ionophore. The effect of
PMA was substantially reduced by blockade of mitogen-activated
protein kinase kinase (MEK), a kinase upstream of mitogen-
activated protein kinase (MAPK)/extracellular signal-regulated
kinase (ERK) (Nagamoto-Combs et al., 1999). Interestingly, it has
been shown that transforming growth factor-beta (TGF-β) stimu-
lates LIFmRNA levels in Schwann cells, and this effect is mediated
through protein kinase C (Matsuoka et al., 1997). Which of these
second messenger pathways are involved in LIF induction after
axotomy is not known?
While immunohistochemistry revealed CNTF-IR in myeli-
nated Schwann cells in the sciatic nerve, no staining was seen
in non-myelinating Schwann cells in the SCG (Dobrea et al.,
1992). To determine whether CNTF was present in the extracts
of non-neuronal cell conditioned medium, a CNTF bioassay was
used (i.e., survival of and process outgrowth from chick ciliary
neurons). No evidence for CNTF bioactivity in the medium con-
ditioned by SCG non-neuronal cells was found. Later studies
revealed that, while low levels of CNTF mRNA are detectable in
the SCG by real-time PCR, the levels do not change after axotomy
(Habecker et al., 2009).
To test the role of LIF in neuropeptide induction after injury
in vivo, experiments were performed with LIF null mutant mice
(Escary et al., 1993). When the two major postganglionic trunks
of the SCG were transected in adult mice and peptide IR was
assayed, the increases in expression of VIP, galanin, and neu-
rokinin A (a peptide that together with substance P is produced
from the β-preprotachykin precursor protein) were significantly
reduced in the LIF –/– mice compared to wild type animals (Rao
et al., 1993a). In addition, these knockout mice exhibited a partial
reduction in the increase in VIP and galanin mRNA following
axotomy (Sun and Zigmond, 1996a). These findings constitute
the first evidence for an effect of endogenous LIF on the nervous
system in vivo. Interestingly, in these LIF –/– mice, small but sig-
nificant increases in the peptides and their mRNAs were still seen
(Rao et al., 1993a). A likely explanation of these partial effects
of the gene deletion is that additional biological activities are
involved. It is striking that in these mutant animals the develop-
mental switch of certain sympathetic neurons from an adrenergic
to a cholinergic phenotype was unaffected, indicating that, con-
trary to expectations, LIF does not play a necessary role in that
process (Rao et al., 1993a).
INVOLVEMENT OF OTHER gp130 CYTOKINE FAMILY
MEMBERS
LIF and CNTF belong to a family of cytokines, which is referred
to as either the interleukin (IL)-6 family or the gp130 family.
This family is quite large and includes, among other cytokines,
IL-6, IL-11, oncostatin M, and cardiotrophin-1 along with LIF
and CNTF (Taga and Kishimoto, 1997), with newmembers of the
family still being identified (e.g., IL-31; for review see Cornelissen
et al., 2011). These cytokines are pleiotropic and have overlap-
ping functional effects. Members of the IL-6 family are identified
by virtue of their three-dimensional structure, rather than by sig-
nificant homology in their amino acid sequence, and form four
anti-parallel helix bundles (Bazan, 1991). The name gp130 fam-
ily, which we will adopt, is based on the fact that members of the
family act on heteromeric receptors, the intracellular signaling
component of which is the protein gp130 (Taga and Kishimoto,
1997).
When mRNA for the six cytokines mentioned above was
measured after axotomy in the SCG in vivo, IL-6, IL-11, and
oncostatin M were found to increase rapidly together with LIF
(Habecker et al., 2009). In order to block the action of all of the
members of this peptide family, we used mice in which gp130 had
been conditionally knocked out in neurons expressing dopamine-
β-hydroxylase (DBH), i.e., in sympathetic neurons, central nora-
drenergic and adrenergic neurons, and adrenal chromaffin cells
(Stanke et al., 2006; for a review on the use of gp130 conditional
knockouts see Fasnacht and Muller, 2008). Axotomy of the SCG
in these knockout animals blocked the axotomy-induced increase
in mRNAs for VIP, PACAP, and galanin completely. Strikingly, the
increase in CCK mRNA was unaffected by the receptor deletion
(Figure 1) (Habecker et al., 2009). This result is somewhat sur-
prising given that, in an early study, LIF was shown to increase
CCK in cultured neonatal SCG neurons (Fann and Patterson,
1993). At present, the signal leading to the axotomy-induced
increase in CCK mRNA in vivo remains to be determined.
While detailed studies on the role of gp130 cytokines on
peripheral neurons after axotomy has been restricted to sympa-
thetic neurons, experiments in LIF –/– animals have also been
carried out in the DRG after sciatic nerve transection, and the
increase in galanin-IR and galanin mRNA were found to be par-
tially blocked (Corness et al., 1996; Sun and Zigmond, 1996b).
In these same studies, no significant decrease occurred in the
induction of NPY. In contrast to the partial dependence of the
axotomy-induced increase in galanin mRNA in the DRG on LIF,
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FIGURE 1 | Regulation of mRNA expression for several neuropeptides
in the SCG after unilateral axotomy. Wild type and gp130DBHcre mice
were subjected to unilateral axotomy of the SCG, and mRNA levels for
several neuropeptides and proteins were measured 48h later in the
ipsilateral (Ax) and contralateral (Sh) ganglia. The data are expressed relative
to GAPDH mRNA in the same samples and represent the means ± S.E.M.
of 4–5 ganglia for VIP (A), galanin (B), and PACAP (C). These three mRNAs
increased in the ipsilateral ganglia of the wild type mice 16-, 7-, and 28-fold,
respectively, but did not increase in ganglia from knockout animals.
However, cholecystokinin (CCK) mRNA was increased similarly in
axotomized ganglia of mice of both genotypes (D). ∗Indicates p < 0.05
compared to sham-operated ganglia of the same genotype compared by
Student’s t-test. The figure is from Habecker et al. (2009).
a normal response was found in IL-6 –/– mice (Murphy et al.,
1999). LIF administration into the sciatic nerve increased the
number of neurons in the DRG expressing galanin but did not
affect the expression of VIP or NPY (Thompson et al., 1998).
In axotomized facial motor neurons, increases in PACAP and
VIP mRNA did not differ between wild type mice and mice null
for either LIF or IL-6 (Armstrong et al., 2003). Nevertheless,
facial motor neurons express gp130 (Haas et al., 1999), and gp130
cytokines are known to affect the survival of these neurons after
axotomy (Sendtner et al., 1996). It would certainly be of interest to
examine PACAP and VIP expression in facial motor neurons after
axotomy in mice with a conditional knockout of gp130 restricted
to motor neurons.
Additional cytokines in this family, or at least related to it, con-
tinue to be identified. An example is IL-31 (Cornelissen et al.,
2011). While neither the presence of nor the action on peripheral
neurons have been described for this cytokine, IL-31 receptors
have been identified in the rodent and human dorsal root gan-
glion (Bando et al., 2006; Sonkoly et al., 2006). Current data
suggest that the IL-31 heterodimeric receptor is made up of the
oncostatin M receptor and the IL-31 receptor α and does not
involve gp130, thus making it quite unusual (Cornelissen et al.,
2011). Nevertheless, one hypothesis is that the IL-31 receptor α
arose by gene duplication of gp130 and that it retains many of
the functions of the latter such as binding to Janus kinases (JAKs)
and Signal Transducers and Activators of Transcription (STAT), a
signal pathway discussed in more detail below (Cornelissen et al.,
2011). The reason for mentioning this here is to raise the possi-
bility that we may well have not accounted for all of the cytokines
that are involved in the response of the peripheral nervous system
to injury.
INTERACTION OF POSITIVE AND NEGATIVE SIGNALS IN
TRIGGERING CHANGES IN PERIPHERAL NEURONS
Having established a role for LIF in the axotomy-induced increase
in galanin mRNA, we examined the effect of placing a pellet of
LIF next to the SCG in an intact animal. We were surprised that
galanin was not induced under these conditions (Sun et al., 1993).
We also observed that there was an increase in LIF expression in
the SCG after deafferentation but little change in galanin expres-
sion (Shadiack et al., 1998). It appeared that LIF only induced
galanin after axotomy. One signal that would correlate with the
SCG neurons being in fact axotomized and no longer connected
to their targets is a decrease in NGF in the ganglion (Korsching
and Thoenen, 1985; Nagata et al., 1987; Zhou et al., 1994). We,
therefore, examined the effect of the LIF pellet in intact ani-
mals in which we had injected antiserum to NGF to lower the
level of this trophic factor in the ganglion (Shadiack et al., 1998).
While injection of the antiserum alone in animals with a placebo
pellet stimulated galanin expression somewhat, the combination
of anti-NGF and the LIF pellet produced a dramatic synergistic
effect (Figure 2). In addition, other animals in which LIF was
increased in the SCG by deafferentation were also injected with
anti-NGF. In those animals there was a small increase in galanin
mRNA in response to either deafferentation or anti-NGF, but
there was a synergistic effect if the two treatments were given
together (Shadiack et al., 1998).
Experiments with explanted SCG also suggested an antago-
nistic relationship between LIF and NGF on galanin expression.
As already noted the high levels of galanin-IR seen after 48 h in
explant culture can be inhibited by a neutralizing antiserum to
LIF (Sun et al., 1994). In addition, these levels can be substan-
tially reduced by addition of NGF, an effect that can be blocked
by an antiserum to NGF (Figure 3; Shadiack et al., 2001). Similar
experiments were carried out in embryonic DRG neurons. In
that case, NGF completely blocked the effect of LIF to elevate
galanin mRNA (Corness et al., 1998). In vivo, the increase in
galanin mRNA that occurs in the DRG after sciatic nerve tran-
section, can be partially reversed by intrathecal administration
of NGF (Verge et al., 1995). While the mechanism behind these
interactions between NGF and gp130 cytokines is not fully under-
stood, NGF has been shown to inhibit the axotomy-induced
activation of the transcription factor STAT3 (Rajan et al., 1998),
which as discussed below seems to mediate many of the effects of
gp130 cytokines after axotomy. It should be noted, however, that
in PC12 cells, NGF actually stimulates STAT3 phosphorylation
(albeit at a different amino acid residue than gp130 cytokines)
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FIGURE 2 | Treatment with anti-NGF alters the responsiveness to LIF
of intact sympathetic neurons in vivo. Messenger RNA levels were
measured by northern blot analysis of SCG that were either untreated
(unop), treated with NSS and a placebo pellet (NSS/Pl), treated with NSS
and a LIF-containing slow-release pellet (NSS/LIF), treated with anti-NGF
and a placebo pellet (αNGF/Pl), or treated with anti-NGF and a LIF pellet
(αNGF/LIF). Treatment with antiserum or control serum was for three days,
while with LIF pellets or control pellets were for two days. In the NSS/Pl
group, there was only a small increase in galanin mRNA levels over the
untreated group, probably due to a small amount of neural damage from
desheathing the SCG which was done before pellet placement. Levels of
galanin mRNA in the NSS/LIF group were not different from those in the
NSS/Pl group. There was a 3.5-fold increase in galanin mRNA in the
αNGF/Pl group as compared with NSS/Pl treatment. The αNGF/LIF group
showed the highest levels of galanin mRNA in this experiment, being
2.3-fold higher than the αNGF/Pl group. Levels of galanin mRNA are
expressed as a ratio of that of GAPDH in the same sample. The bar graph
represents the means ± SEM of data from five or six samples per group
with two SCG per sample. ∗p, 0.0001 compared with NSS/Pl. ∗∗p, 0.0001
compared with either NSS/LIF or αNGF/Pl. The autoradiograph is from one
representative experiment and contains multiple lanes of the groups
described above. Lanes 1 and 2, unop; lanes 3–5, NSS/Pl; lanes 6–8,
NSS/LIF; lanes 9–11, αNGF/Pl; and lanes 12–14, αNGF/LIF. After the blot
was probed for galanin, it was stripped and re-probed for GAPDH. The
figure is from Shadiack et al. (1998).
and the binding of the transcription factor to DNA (Ng et al.,
2006). The reason for this apparent discrepancy remains to be
determined.
CYTOKINE DEPENDENCE OF OTHER REGENERATION
ASSOCIATED GENES OR DOWNSTREAM EFFECTORS
Neuropeptides are not the only genes that are up-regulated
after axotomy via gp130 cytokines. The best studied cytokine-
dependent RAG after VIP is a membrane-bound metallopepti-
dase, damage-induced neuronal endopeptidase (DINE), which is
increased after axotomy in a variety of motor nuclei, in DRGs,
FIGURE 3 | NGF inhibits the increase in galanin-IR and this effect is
completely reversed by an NGF antiserum. Adult SCG were cultured for
48 h in F12 medium alone or in the presence of 50 ng/ml NGF. To some of
the NGF-treated cultures we also added different concentrations of an
antiserum to NGF. Galanin-IR was assayed by radioimmunoassay in
individual SCG. Data are the means of six ganglia ± SEM; ∗p, 0.004 vs.
control and ∗∗p, 0.02 vs. NGF. The figure is from Shadiack et al. (2001).
and in SCGs (Kiryu-Seo et al., 2000; Boeshore et al., 2004). LIF,
but not CNTF or IL-6, increased DINE mRNA in organ cul-
tured neonatal DRG and injection of LIF into the sciatic nerve
in vivo led to a similar increase in the axotomized DRGs (Kato
et al., 2002). Furthermore, the increase in DINE mRNA in the
DRG after sciatic nerve injury was partially blocked by injecting
an anti-gp130 antibody into the injured nerve (Kato et al., 2002).
LIF also stimulated activity in a DINE promoter assay (Kiryu-Seo
et al., 2008). Interestingly, the participation of STAT3 in regu-
lating DINE expression does not seem to be due to its direct
binding to a cytokine response element, rather it has been hypoth-
esized that STAT3 plus two other transcription factors, which are
up-regulated after axotomy, ATF3, and c-Jun, interact with the
general transcription factor, Sp1, which in turn binds to a GC box
within the DINE promoter.
In addition to DINE and the neuropeptides discussed above,
mRNA for one of the rat substance P receptors is increased
in the SCG after axotomy (Ludlam et al., 1995), and studies
in vitro demonstrate that LIF and CNTF can increase this message
in both dissociated and explanted sympathetic neurons (Ludlam
et al., 1994). Pancreatitis-associated protein, referred to as REG-
2, is up-regulated in sensory, motor, and sympathetic neurons
after axotomy (Livesey et al., 1997; Boeshore et al., 2004), and its
expression has been shown to be sensitive to gp130 cytokines act-
ing through STAT3 (Livesey et al., 1997; Nishimune et al., 2000;
Schweizer et al., 2002). The neuronal intermediate filament pro-
tein peripherin increases after axotomy in the DRG and in spinal
motor neurons (Oblinger et al., 1989; Troy et al., 1990; Wong
and Oblinger, 1990), contains a gp130 cytokine response element
(Lecomte et al., 1998), and is induced by IL-6 in PC12 cells and
by LIF in a neuroblastoma cell line (Sterneck et al., 1996; Lecomte
et al., 1998). Finally, IL-6 has been shown to increase growth
associated protein- 43 (GAP-43) in PC12 cells (Marz et al., 1997),
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and the increase in GAP-43 normally seen in DRGs after axotomy
is abolished in IL-6 –/– mice (Cafferty et al., 2004). Whether the
effects of gp130 cytokines on the expression of the proteins men-
tioned in this paragraph are “direct” (i.e., whether the respective
genes have a gp130 cytokine response element) and whether the
increases in mRNA expression after axotomy are dependent on
gp130 cytokines has not been examined in every case.
In a recent paper, IL-6 was shown to mediate chloride accu-
mulation in axotomized sensory neurons via the phosphorylation
of the Na+, K+, Cl− cotransporter NKCC1 (Pieraut et al., 2011).
This phenomenon is relevant because NKCC1 phosphorylation
and intracellular chloride accumulation has been shown to stim-
ulate neurite outgrowth in axotomized DRG neurons in culture
(Pieraut et al., 2007). The effect of IL-6 is blocked by inhibitors
of JAK; however, the kinase that phosphorylated NKCC1 has
not been identified. In vivo, axotomy leads to increased NKCC1
phosphorylation without a change in the level of transcripts for
this cotransporter. Increased phospho-NKCC1 was not seen after
axotomy in IL-6 –/– mice (Pieraut et al., 2011).
CYTOKINE RECEPTORS IN NORMAL AND AXOTOMIZED
PERIPHERAL NEURONS
By definition, all gp130 cytokines act through a receptor that con-
tains one or perhaps two gp130 subunits. This subunit is present
in intact neurons in the SCG (Wong et al., 1995), DRG (Gardiner
et al., 2002), and cranial and spinal motor nuclei (Watanabe
et al., 1996). gp130 mRNA does not change after axotomy in SCG
(Banner and Patterson, 1994), DRG (Gardiner et al., 2002; Brazda
et al., 2009) or facial motor neurons (Haas et al., 1999).
The exact subunit composition of the receptor with which
gp130 cytokines interact varies for each cytokine. For example,
LIF interacts with a heterodimer made up of a gp130 subunit and
a LIF receptor, while IL-6 interacts with a heterotrimer made up
of two gp130 subunits and a specific IL-6 receptor (e.g., Heinrich
et al., 1998). The regulation of the expression of the LIF recep-
tor is different in different types of peripheral neurons. In the
SCG, LIF receptor mRNA decreases after axotomy (Banner and
Patterson, 1994), in the DRG, the level of the receptor remains
constant though its subcellular localization is said to be altered
from nucleus to cytoplasm (Gardiner et al., 2002), while in facial
motor nucleus and ventral horn the LIF receptor increases (Haas
et al., 1999; Hammarberg et al., 2000). In spite of this diversity,
however, as noted previously, LIF affects each of these classes of
neurons after axotomy.
With regard to the IL-6 receptor, the situation in the SCG and
DRG is not completely clear. It has been reported by RT-PCR
and in situ hybridization that IL-6 receptor mRNA is expressed
in neurons in both adult SCG and DRG (Gadient and Otten,
1996; Marz et al., 1996; Shuto et al., 2001); however, in pharma-
cological studies with cultured neonatal SCG neurons, addition
of IL-6 in the absence of the IL-6 soluble receptor apparently
produced little effect on neuropeptide expression (Marz et al.,
1998). In seeming contrast, intrathecal injection of IL-6 by itself
led to an increase in expression of galanin mRNA in the DRG
(Murphy et al., 1999). Using either neurite outgrowth or neu-
ronal survival as an assay, a dependence of IL-6’s action on the
addition of a soluble IL-6 receptor in embryonic and newborn
DRG neurons respectively has been reported (Hirota et al., 1996;
Thier et al., 1999). Nevertheless, in adult DRG explants or in
isolated adult DRG neurons (in the presence of NGF), IL-6 did
not require the addition of a soluble IL-6 receptor to stimu-
late neurite outgrowth (Shuto et al., 2001; Cafferty et al., 2004).
Unfortunately, the level of IL-6 receptor protein in these studies
was not assessed. In this context, it is interesting to note that in
hypoglossal neurons IL-6 receptor protein measured by immuno-
histochemistry was increased dramatically one week after axo-
tomy (Hirota et al., 1996). In the facial motor neurons after a
unilateral facial nerve lesion, however, IL-6 receptor IRwas clearly
visible and no differences were noted on the ipsilateral and con-
tralateral motor nucleus two days after the lesion (Klein et al.,
1997).
The findings that in some situations exogenous IL-6 does
not produce an effect unless exogenous soluble IL-6 receptor
is also added has led to the concept of trans-signaling (Marz
et al., 1999; Jones et al., 2001; Rose-John, 2003; Jones et al.,
2005). The idea is that certain targets of IL-6 express gp130
though not the IL-6 receptor, but that a soluble form of the IL-
6 receptor is expressed and released by nearby cells, and, after
combining with IL-6, leads to activation of gp130. While at
least two studies have described this phenomenon in the cen-
tral nervous system (CNS) (Linker et al., 2008; Burton et al.,
2011), we are not aware of any demonstration of such signal-
ing involving neurons; however, perhaps the dorsal root gan-
glion is a system worth examining where one can imagine IL-6
receptors being released by satellite/Schwann cells and facili-
tating the autocrine stimulation of neurons (see further dis-
cussion below). In this regard, IL-6 receptors were shown to
increase in DRG satellite cells after chronic sciatic nerve constric-
tion (Dubovy et al., 2010), though not after nerve transection
(Pieraut et al., 2011), and to increase in Schwann cells in the
sciatic nerve after a nerve crush (Bolin et al., 1995). Another
possibility would be the release of soluble IL-6 receptors by
macrophages (Horiuchi et al., 1994), which are known to infil-
trate into sensory and sympathetic ganglia following axotomy
(Lu and Richardson, 1993; Schreiber et al., 1995), although at
least in the SCG this occurs with some delay after the peak
in IL-6 induction (Habecker et al., 2009). Finally, it should be
noted that soluble receptors also exist for other gp130 cytokines
(Jones and Rose-John, 2002) and could be involved in trans-
signaling.
WHAT ARE THE MOLECULAR MECHANISMS BY
WHICH CYTOKINES LEAD TO PEPTIDE INDUCTION
AFTER AXOTOMY?
gp130 cytokines can act on neurons by at least two signaling path-
ways (Taga and Kishimoto, 1997). One of these is the JAK/STAT
pathway, in which occupation of a cytokine receptor leads to
the activation of a JAK and the phosphorylation, activation, and
nuclear translocation of a STAT transcription factor, leading to
its binding to a cytokine response element on a gene promoter.
gp130 receptor stimulation can also lead to activation of the
Ras/MAPK pathway.
Almost all studies on cytokine action on peripheral neurons
have focused on the first such pathway. Two exceptions involve the
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cytokine suppression of the adrenergic phenotype in a neuroblas-
toma cell line (Dziennis and Habecker, 2003; Shi and Habecker,
2012). In the first study, inhibition of ERK kinase was shown to
block the decrease in DBH protein produced by CNTF, though
somewhat surprisingly not the decrease in DBH mRNA. In the
second study, CNTF increased the ubiquitination of tyrosine
hydroxylase and decreased the protein half-life of the enzyme, and
these effects were blocked by an ERK kinase inhibitor but not by
a STAT3 inhibitor. A final example of an ERK-mediated gp130
cytokine action concerns IL-6-induced allodynia (Melemedjian
et al., 2010). In this system, IL-6 leads to ERK phosphorylation
which leads to the activation of MAP kinase-interacting kinase 1
(Mnk1) which causes the phosphorylation of the eukaryotic ini-
tiation factor (eIF) 4E leading to enhanced protein translation.
Notably all three examples cited demonstrate cytokine effects on
protein levels, which are not mediated through changes in gene
transcription.
In contrast to these ERK-mediated effects of gp130 cytokines,
the regulation of VIP expression by CNTF and LIF in a neu-
roblastoma cell line indicated that these inductions occur by a
Ras-independent pathway (Johnson and Nathanson, 1994). LIF
stimulates the binding of STAT3 to the cytokine response element
in the VIP gene in cultured sympathetic neurons (Symes et al.,
1994). In a neuroblastoma cell line, deletion of this DNA bind-
ing site for STAT attenuated the transcription of VIP by gp130
cytokines (Symes et al., 1994). Further studies indicated that addi-
tional transcription factors also act within the cytokine response
element in the stimulation of VIP expression by LIF and CNTF
(Symes et al., 1995); however, the role of such factors in the
response to axotomy remains unclear.
The role of the JAK/STAT pathway in the regulation of PACAP
and galanin does not seem to have been explored beyond the
observation that an enhancer region in the galanin promoter that
is necessary for axotomy-induced up-regulation in the DRG after
sciatic nerve transection contains an 18 bp region with overlap-
ping putative Stat-, Smad-, and Ets-binding sites and a 23 bp
region with adjacent Stat and Smad-binding sites (Bacon et al.,
2007). Interestingly, using bioinformatics, it was found that three
other RAGS (VIP, NPY, and GAP-43) had similar sites in their
enhancer regions. Finally with respect to galanin expression, there
is a high degree of colocalization of c-Jun and galanin expres-
sion in DRG neurons after axotomy (Herdegen et al., 1993), and
c-Jun has been implicated in galanin induction in axotomized
facial motor neurons (Raivich et al., 2004). In sensory neurons,
c-Jun induction after axotomy has been attributed in part to the
decreased availability of a negative factor, NGF (Gold et al., 1993,
1994) as has the induction of galanin (Shadiack et al., 1998, 2001).
STAT3 phosphorylation occurs after peripheral axotomy in
sympathetic, motor, and sensory neurons (Figure 4; Rajan et al.,
1995; Haas et al., 1999; Schwaiger et al., 2000; Qiu et al., 2005).
In the facial motor nucleus, where no cytokine dependence of
neuropeptide gene expression has yet been demonstrated, STAT3
phosphorylation occurs within 12 h after facial nerve lesion, but
this occurrence is delayed a further 12 h in CNTF –/– mice, indi-
cating a cytokine influence on the activation of this transcription
factor. Interestingly, no activation of STAT3 occurred following
transection of axons in two systems in the CNS, namely axons
A B
FIGURE 4 | Phospho-STAT3 immunostaining in sections of SCG after
axotomy. Forty eight hours after unilateral axotomy, phospho-STAT3
immunostaining was seen in sections of the ipsilateral SCG from wild type
(A), but not from gp130DBHcre (B), mice. Scale bar = 50μm. The figure is
from Habecker et al. (2009).
of neurons in Clarke’s nucleus and the central processes of DRG
neurons in the dorsal columns, neither of which exhibit regen-
eration (Schwaiger et al., 2000; Qiu et al., 2005). The possible
significance of the lack of STAT3 activation in injured CNS
neurons is raised toward the end of this review.
While Rajan et al. (1995) reported that axotomy of the SCG in
LIF –/– mice produced no activation of STAT3, we found that the
increase in STAT3 phosphorylation, though significantly inhib-
ited in those animals, was not abolished (Mohney, 1998). On
the other hand, no STAT3 phosphorylation was seen in the SCG
after axotomy in gp130 conditional knockout mice (Figure 4;
Habecker et al., 2009; Hyatt Sachs et al., 2010), again suggest-
ing the involvement of more than one cytokine in the response
to axotomy.
A puzzling aspect about phospho-STAT3 activation after axo-
tomy, at least in the DRG where it has been studied in detail, is its
time course. After sciatic nerve transection phospho-STAT3 was
maximal in the DRG after 6 h but was still above control values
after a month (Qiu et al., 2005). However, the level of LIF mRNA
in the sciatic nerve, though initially elevated had returned to con-
trol levels between 7 and 14 days after transection (Curtis et al.,
1994). It will be interesting to learn what is responsible for the
sustained phosphorylation/activation of this transcription factor.
PARACRINE, AUTOCRINE, AND RETROGRADE MECHANISMS
OF gp130 CYTOKINE ACTION ON NEURONS
Although emphasis has been placed thus far in this review on the
synthesis and release of LIF from satellite/Schwann cells within
sympathetic ganglia and its paracrine action on the axotomized
neurons, LIF can also be synthesized in Schwann cells in axons
distal to the injury and retrogradely transported by sensory and
motor neurons (Banner and Patterson, 1994; Curtis et al., 1994;
Kurek et al., 1996; Sun and Zigmond, 1996b; Thompson et al.,
1997). Retrograde transport of LIF (and of CNTF) is actually
increased following nerve injury (Curtis et al., 1993, 1994). The
transport of radioactive LIF by sensory neurons and spinal motor
neurons is specific to LIF and is not inhibited by administration
of other cytokines (e.g., CNTF, oncostatin M, and IL-6 with or
without the IL-6 soluble receptor; Curtis et al., 1994).
In contrast, following injection of radioactive LIF into
the foot pad, no transport of the cytokine to adult lumbar
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sympathetic ganglia was seen (Hendry et al., 1992). This find-
ing is somewhat surprising since neonatal sympathetic neurons in
compartmentalized cultures retrogradely transport LIF (Ure and
Campenot, 1994). In addition, early studies led to the hypoth-
esis that LIF produced by certain sympathetic target tissues, in
particular the sweat gland, could produce a switch in neonatal
sympathetic neurons in vivo from an adrenergic to a choliner-
gic phenotype (Yamamori et al., 1989; Rao and Landis, 1993).
However, later studies in which the gp130 cytokines present in the
sweat gland were identified and in which the “cholinergic switch”
was shown to be normal in LIF –/– mice indicated that LIF is not
the gp130 cytokine that is responsible from this retrograde effect
(Rao et al., 1993a; Stanke et al., 2006). It remains possible that
LIF can be transported by neonatal sympathetic neurons but not
adult neurons or by cultured neurons but not neurons in vivo,
though the later possibility seems unlikely.
Consistent with the view that some effects of gp130 cytokines
involve a retrograde action, STAT3 phosphorylation is seen in
cell bodies of sympathetic neurons in compartmentalized cul-
tures after application of LIF to their distal neurites (O’Brien and
Nathanson, 2007). Based on this and other data, these workers
present a model that LIF bound to its receptor is retrogradely
transported to the neuronal cell body in a signaling endosome,
analogous to the retrograde mechanism of neurotrophin signal-
ing (Wu et al., 2009). In cell bodies of facial motor neurons, STAT
activation following nerve injury can be delayed by three days fol-
lowing treatment with a blocker of axonal transport, colchicine
(Kirsch et al., 2003).
In the case of DRG neurons, sciatic nerve transection does not
lead to an increase in LIF mRNA within the DRG, though it does
in the distal nerve segment (Curtis et al., 1994; Sun and Zigmond,
1996b). Interestingly, DRGs placed in organ culture increased
their LIF mRNA dramatically; however, only a slight increase was
shown in vivo when both the peripheral and central branches of
their axons were cut (Sun and Zigmond, 1996b). However, the
increase in galanin was reduced in the axotomized DRG from a
LIF –/– mouse compared to a wild type mouse, suggesting an
involvement of the retrogradely transported LIF originating in
the distal nerve stump (Sun and Zigmond, 1996b). We believe
that this is the first demonstration of an often hypothesized phe-
nomenon, namely an effect on an axotomized neuron of a trophic
factor or cytokine produced by the distal nerve following injury.
While the neurons in sympathetic ganglia and motor nuclei
are generally considered homogenous in terms of trophic factor
and cytokine effects, DRG are clearly heterogeneous (e.g., Verge
et al., 1995; Marmigere and Ernfors, 2007). In a study on the
retrograde transport of biotinylated LIF, the cytokine was found
predominantly in small diameter DRG neurons of both the calci-
tonin gene-related peptide positive (CGRP+) and the isolectin B4
positive (IB4+) subtypes (Thompson et al., 1997). Interestingly,
these were the predominant neuronal subtype showing cytoplas-
mic LIF receptor after sciatic nerve transection (Gardiner et al.,
2002).
In addition to these paracrine and retrograde mechanisms, it
has been suggested that these cytokines can act in an autocrine
mechanism. In situ hybridization studies demonstrated IL-6
mRNA in DRG neurons after sciatic nerve transection (Murphy
et al., 1995), although an increase in satellite glial cells in these
ganglia has also recently been reported (Dubovy et al., 2010).
While IL-6 is increased distal to a sciatic nerve lesion (Bolin et al.,
1995), in the case of this cytokine, retrograde transport does not
seem to occur (Kurek et al., 1996). It would be interesting if this
failure of retrograde transport was related to a low level of IL-
6 receptor protein in DRG neurons. Finally, galanin induction
in the axotomized DRG is reduced in the IL-6 –/– mouse, sug-
gesting that the neuronal IL-6 plays an autocrine and (perhaps a
paracrine) role in this system. As noted already, such an autocrine
action might involve trans-signaling between neurons and satel-
lite cells. While it has also been proposed that in cultured SCG
neurons LIF can also play an autocrine role on neuropeptide gene
expression (Cheng and Patterson, 1997), the importance of such
an action in the SCG compared to LIF’s paracrine and retrograde
actions is unknown.
THE CONDITIONING LESION RESPONSE IN SENSORY
AND SYMPATHETIC NEURONS AND ITS DEPENDENCE
ON gp130 CYTOKINES
In terms of the effects of gp130 cytokines on axonal growth
after axotomy, the best studied system is the conditioning lesion
response in sensory and sympathetic neurons. This response was
first described by McQuarrie and Grafstein as an increase in the
rate of growth of silver stained axons in the sciatic nerve follow-
ing a test lesion if that nerve had been lesioned several days earlier
(McQuarrie and Grafstein, 1973). Later studies showed that this
conditioning effect occurred in all three fiber types in that nerve,
i.e., motor, sensory, and sympathetic (McQuarrie et al., 1977;
McQuarrie, 1978; Navarro and Kennedy, 1990).
In addition to an increased rate of regeneration in vivo, it was
later found that a conditioning lesion also increased the rate of
neurite outgrowth observed subsequently in vitro in explants of
DRG or SCG (Edstrom et al., 1996; Shoemaker et al., 2005) or
in cultures of dissociated neurons from those ganglia (Hu-Tsai
et al., 1994; Shoemaker et al., 2005). Although neurite outgrowths
of sensory neurons in vitro are normally inhibited in the pres-
ence of the myelin protein, myelin associated glycoprotein (MAG)
(Mukhopadhyay et al., 1994), this inhibition is abolished by a
conditioning lesion (Qiu et al., 2002). While striking, the func-
tional significance in vivo of inhibition of neurite outgrowth by
myelin proteins remains controversial. The axons of transplanted
DRG axons have been shown to grow for long distances in CNS
white matter, including in areas of degenerating myelin (Davies
et al., 1999). Furthermore, experiments with triple knockoutmice
for MAG and the two other myelin inhibitory proteins that have
been examined in detail have produced conflicting results as to
the effects of these deletions on CNS regeneration (Cafferty et al.,
2010; Lee et al., 2010).
Perhaps the most dramatic effect of a conditioning lesion that
has been reported is its effect on growth of sensory neurons into
the CNS. When the peripheral branch of a DRG neuron is tran-
sected, the axons are capable of regeneration. Normally this is
not true when the central branch of these neurons is lesioned
(Ramon y Cajal, 1928); however, following a conditioning lesion
of the peripheral branches, the lesioned central axons are capa-
ble of regenerating both into a peripheral nerve graft (Richardson
Frontiers in Molecular Neuroscience www.frontiersin.org January 2012 | Volume 4 | Article 62 | 9
Zigmond gp130 cytokines as injury signals
and Issa, 1984) and into the dorsal columns of the spinal cord in
the absence of such a graft (Neumann and Woolf, 1999).
The first evidence for the involvement of the JAK/STAT
pathway and thereby, perhaps, of gp130 cytokines in the condi-
tioning lesion response was that of Liu and Snider (2001). These
investigators looked at the effects of the JAK inhibitor tyrphostin
(AG490), which blocks the phosphorylation of STAT3 by JAK2.
Administration of this inhibitor in culture blocks the increased
outgrowth seen by DRG neurons that have previously received
a conditioning lesion (Liu and Snider, 2001). Interestingly, these
researchers also reported that inhibitors of the ERK kinase path-
way, which as expected blocked NGF stimulated neurite out-
growth from embryonic DRG neurons, had no effect on the
conditioning lesion response. Subsequent studies demonstrated
that AG490 administered in vivo blocked ingrowth of DRG axons
into the dorsal columns (Qiu et al., 2005). In addition, two
recent molecular screens on DRGs involving gene microarray
analysis, phosphoproteomics or differential hybridization, and
bioinformatics have identified STATs generally, or STAT3 specif-
ically, as transcription factors involved in nerve regeneration
(Michaelevski et al., 2010; Smith et al., 2011).
It has been well established that analogs of cAMP whether
added to a culture of DRG neurons (Cai et al., 1999; Hannila and
Filbin, 2008) or injected into the ganglion in vivo (Neumann et al.,
2002; Qiu et al., 2002) leads to a conditioning lesion-like growth
response. Furthermore, a conditioning lesion leads to an increase
in cAMP levels in the DRG (Qiu et al., 2002; Udina et al., 2008).
The effect of cAMP on neurite growth on MAG when tested on
cerebellar neurons is blocked by an inhibitor of RNA transcrip-
tion [5,6,-dichlorobenzimidazol ribose (DRB)] (Cai et al., 2002).
In contrast, others have reported that the cAMP mediated stim-
ulation of DRG neurite outgrowth on a permissive substrate is
not blocked by DRB at a concentration at which RNA synthesis is
blocked by>95% (Andersen et al., 2000). Interestingly, injections
of cAMP into the DRG in vivo lead to an increase of the mRNAs
for both IL-6 and LIF and to the phosphorylation and nuclear
localization of STAT3 (Wu et al., 2007). Furthermore, the ability
of cAMP to stimulate the percentage of DRG neurons with neu-
rites when cultured on a permissive substrate was slightly blocked
by AG490 (Wu et al., 2007).
The conditioning lesion effect has been examined also in
knockouts of specific gp130 cytokines. The effect of a condition-
ing lesion on neurite outgrowth of DRG neurons on a permissive
substrate was decreased by about 40% in LIF –/– mice (Cafferty
et al., 2001). Interestingly, addition of exogenous LIF into the cul-
tures restored this deficit. In a recent study, it was found that only
certain DRG neurons show enhanced neurite outgrowth after
a conditioning lesion (Kalous and Keast, 2010). Somewhat sur-
prisingly, those cell types that did not show this effect were the
CGRP+ and IB4+ neurons, the very neurons that, as previously
noted, showed cytoplasmic localization of LIF receptors and ret-
rograde transport of LIF (Thompson et al., 1997; Gardiner et al.,
2002). This issue obviously requires further study.
In IL-6 –/– mice, the effect of prior transection of the sci-
atic nerve on subsequent neurite outgrowth in vitro was reduced
by about 65% (but see below), and addition of exogenous IL-6
to these neurons restored the normal conditioning lesion effect
(Cafferty et al., 2004). These results, together with the experiment
of Liu and Snider discussed above using the JAK/STAT inhibitor,
indicate that, while these cytokines may play a role immediately
following a conditioning lesion, they clearly also play a role in the
subsequent response of the conditioned neurons to the test lesion,
which in these cases is produced when the ganglia are dissociated
and placed in cell culture a week later.
Addition of IL-6 to DRG cultures, like addition of cAMP,
blocks the inhibitory effect of MAG on neurite outgrowth and
both effects are blocked by DRB, the inhibitor of gene transcrip-
tion (Cao et al., 2006). Since cAMP leads to an increase in IL-6
mRNA in these neurons, the hypothesis was tested as to whether
the ability of cAMP to allow growth on this inhibitory substrate
might be mediated through IL-6; however, neither an antibody
to gp130, a soluble chimeric form of gp130 fused to Fc, or
AG490 blocked the growth response to cAMP (Cao et al., 2006).
Furthermore, in contrast to the results of Cafferty discussed
above, no differences in neurite outgrowth by DRG neurons after
a conditioning lesion were found between wild type and IL-6 –/–
either in the presence or absence of MAG. These two groups also
reported different results on the effect of a conditioning lesion on
growth of DRG neurons into the spinal cord after dorsal column
lesions, with Cafferty et al. (2004) finding much less growth in IL-
6 –/– compared to wild type animals and Cao et al. (2006) finding
no difference between the two strains. In contrast to Cafferty
et al., Cao et al. concluded that IL-6 is sufficient, but not neces-
sary, to mediate the conditioning lesion effect. The basis for these
different findings is unknown at present.
Thus far, only one downstream mediator of the effects of
gp130 cytokine on the conditioning lesion response has been
identified, namely galanin (Sachs et al., 2007). Wild type and
galanin –/– mice were examined after unilaterally transecting
the sciatic nerve. One week later, the ipsilateral and contralat-
eral L4 and L5 DRGs were removed, dissociated, and placed in
culture. Neurite outgrowth was greater in neurons isolated from
the ipsilateral ganglia in both genotypes; however, the magnitude
of the effect was significantly greater in wild type animals (Sachs
et al., 2007). Immunohistochemistry established that at the time
the ganglia were placed in culture, galanin-IR was substantially
increased in small and midsize neurons in the ipsilateral wild
type DRGs.
While initially it was believed that sympathetic neurons did not
respond to prior injury with increased growth (McQuarrie et al.,
1978), it was subsequently found that they did (Figure 5; Navarro
and Kennedy, 1990; Shoemaker et al., 2005). When the effect of
a conditioning lesion on neurite outgrowth from SCG neurons
in culture was examined, no differences were found between wild
type and LIF –/– mice either in explant or dissociated cultures
(Shoemaker et al., 2005). However, when the same experiments
were performed in the gp130 conditional knockouts described
above, the stimulation of outgrowth in both preparations was
completely abolished (Figure 5; Hyatt Sachs et al., 2010).
These findings on the dependence of the increased neurite out-
growth after a conditioning lesion on gp130 cytokines is in appar-
ent conflict with a study by Ng et al. on the inhibitory effects of
LIF and CNTF on NGF-directed neurite outgrowth in PC12 cells
and neonatal sympathetic neurons (Ng et al., 2003). In that study,
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FIGURE 5 | (A, B) Neurite outgrowth was measured from explants of SCGs
from wild type (C57) and gp130DBHcre (gp130) mice following unilateral
axotomy. Seven days following surgery, the ipsilateral (Ax) and contralateral
(Sh) SCGs were placed in Matrigel and maintained in culture. Twenty-four
(A) and forty-eight (B) hours later, the explants were photographed under
phase contrast microscopy, and the lengths of the 20 longest neurites were
determined. The data are presented as means ± S.E.M. for nine ganglia at
24 h and for 6–9 ganglia at 48 h. ∗Represents a difference from the control
value of the same genotype at p < 0.003 by a one-way ANOVA followed by
Tukey’s post-test. (C–F). Phase contrast micrographs of SCGs placed in
explant culture for 48 h. Ganglia from wild type (C, E) and gp130DBHcre
(D, F) mice placed in culture seven days after unilateral axotomy. (C) and
(D) represent contralateral and (E) and (F) ipsilateral ganglia. Arrows point
to individual neurites. The scale bar represents 100μm. The figure is
from Hyatt Sachs et al. (2010).
NGF cells was found to induce in PC12 cells mRNA for LIF, onco-
statin M, and the LIF receptor, none of which were detectable in
the absence of NGF. The neurite outgrowth stimulated by NGF in
these cells was enhanced if the cells were transfected with a dom-
inant negative form of the LIF receptor, while overexpression of
the normal LIF receptor inhibited the outgrowth. Data indicated
that cytokines, presumably acting via an autocrine mechanism,
decreased Rac1 activation and increased RhoA activation. In
primary sympathetic neurons, CNTF inhibited NGF-stimulated
neurite outgrowth on day 1 of treatment though the effect was no
longer apparent on day 2. It is hard to reconcile these effects with
those of Cafferty et al. on adult DRG neurons. In their studies,
LIF and IL-6 were shown to stimulate an elongated neurite phe-
notype but only if the cells had been primed with NGF (Cafferty
et al., 2001, 2004). Whether these apparent discrepancies are due
to differences in the age of the neurons, the cell types examined, or
some procedural differences is clearly of interest but remains to be
determined.
MIGHT THE gp130 CYTOKINES SYSTEM BE USEFUL
FOR FACILITATING REGENERATION IN THE CNS?
Unlike the peripheral nervous system, little regeneration occurs
in the CNS after axonal injury. Four recent developments sug-
gest the possibility that activation of the gp130 cytokine system
might facilitate CNS regeneration. Two of these studies involved
the response of retinal ganglion cells (RGCs) to a crush of the
optic nerve. Normally, there is little regrowth by these damaged
axons.
Signaling by gp130 cytokines can be inhibited by a family of
proteins called suppressors of cytokine signaling (SOCS), which
inhibit JAKs (Wang and Campbell, 2002; Heinrich et al., 2003).
To unleash potential gp130 cytokine signaling in a CNS system, a
conditional knockout of SOCS3 was produced in the eye. Mutant
animals whose SOCS3 gene had been floxed received an intravit-
real injection of an adeno-associated virus preparation containing
the coding sequence for CRE. The result was an impressive stim-
ulation of RGC axonal outgrowth (Smith et al., 2009). This
outgrowth was not seen in animals having both SOCS3 and
gp130 knocked out. In situ hybridization indicated an increase in
CNTF mRNA in the ganglion cell layer after optic nerve crush,
though the cell responsible for this expression was not identified.
Injection of CNTF into the eye in the SOCS3 knockout animals
further enhanced axonal regeneration.
Some years ago, it was shown that following injury to the lens,
RGCs could show impressive axonal outgrowth after an optic
nerve crush (Leon et al., 2000). While there has been contro-
versy over the primary mechanism underlying this effect (Muller
et al., 2009; Yin et al., 2009), at least one mechanism operating is
through gp130 cytokines. Thus, LIF and CNTF double knockout
animals do not show the effects of lens injury on neurite out-
growth. In wild type animals, LIF and CNTF mRNA increased
in retinal astrocytes after lens injury, and STAT3 phosphorylation
increased in RGCs (Leibinger et al., 2009).
Two further examples of the possibility of promoting regener-
ation in the CNS via these cytokines and the JAK/STAT pathway
comes from very recent papers in which neurons were trans-
fected with a constitutively active form of STAT3. In one of
these papers, STAT3 was introduced into the DRG by viral gene
transfer (Bareyre et al., 2011). Overexpression of STAT3 led to
increased STAT3 phosphorylation and to a large increase in ter-
minal sprouting by sensory nerve endings after dorsal column
injury. Interestingly, in this same study, a conditional knockout
of STAT3 in DRG neurons greatly reduced nerve outgrowth from
the saphenous nerve after transection (Bareyre et al., 2011). In the
second paper, a constitutively active form of STAT3 was electro-
porated into cerebellar granular cells, which normally have very
low STAT3 expression, and a small (20%) increase in neurite out-
growth was seen in neurons cultured on a permissive substrate
(Smith et al., 2011).
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CONCLUDING THOUGHTS
gp130 cytokines have long been recognized to be pleiotropic
and to have overlapping functions (Taga, 1997). The data dis-
cussed in this review suggest that, in both the sympathetic and
sensory systems, multiple gp130 cytokines play a role in trig-
gering responses of neurons to injury. A similar situation seems
to govern the developmental change in cholinergic properties of
sympathetic neurons innervating sweat glands. In that instance,
in situ hybridization and laser-capture-microdissection followed
by RT-PCR revealed that multiple gp130 cytokines are present in
mouse sweat gland coils (Stanke et al., 2006). Although as already
noted both exogenous LIF and CNTF trigger a cholinergic switch
in these neurons, this switch is not abolished in LIF –/– or CNTF
–/– mice or even in double knockout animals (Francis et al.,
1997). On the other hand, cholinergic development in these neu-
rons is largely absent in the gp130 conditional knockouts (Stanke
et al., 2006), analogous to our findings in adult sympathetic
neurons after injury.
As noted, only one downstream mediator of the effects of
gp130 cytokine on the conditioning lesion response has been
identified, namely galanin, and that only in sensory neurons
(Sachs et al., 2007). The fact that the effect on the conditioning
lesion response of the null mutation for galanin was only partial
suggests that there are other induced proteins involved.
It should be pointed out that all effects of gp130 cytokines
on axotomized neurons need not be direct. Both Schwann cells
and astrocytes are known to have receptors for these cytokines
(Klein et al., 1997; Lee et al., 2009a,b; Wang et al., 2009; Ito et al.,
2010; Kirsch et al., 2010), as do macrophages (Hendriks et al.,
2008). An interesting example of a quite complicated set of inter-
cellular processes involving LIF concerns this cytokine’s ability
to stimulate myelination (Ishibashi et al., 2006). In an in vitro
system, electrical stimulation was shown to lead to the neuronal
release of ATP, which then acts on astrocytes to release LIF, which
finally acts on oligodendrocytes to promotemyelination. Whether
such a pathway plays a role in the myelination of regenerating
axons in vivo is not known. Furthermore, the extent to which sim-
ilar indirect pathways of cytokine action on regenerating neurons
occurs more generally must await future research.
A question long of interest in the regeneration field is to what
extent the changes that occur in the adult during regeneration
recapitulate changes that occur during initial axonal outgrowth
in the embryo and early neonate. The prototypic gene in this
regard is GAP-43, which was identified based on the fact that it
was present in the embryonic nervous system and not present in
the adult except in the peripheral nervous system following nerve
injury, where regeneration takes place (Skene and Willard, 1981).
With regard to another gene discussed in the current review,
galanin has been shown to be expressed in the embryonic DRG
starting at embryonic day 14 but not in the adult DRG except
after axotomy (Xu et al., 1996). Interestingly, however, deletion
of the enhancer region in the galanin gene that completely pre-
vented the axotomy-induced up-regulation of the neuropeptide
had no effect on its developmental expression (Bacon et al., 2007).
The extent that gp130 cytokines play a role in growth associated
genes or in axon elongation during development remains to be
determined.
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